Zacks: Brokerages Expect athenahealth, Inc (ATHN) to Post $0.74 EPS

Analysts forecast that athenahealth, Inc (NASDAQ:ATHN) will announce earnings per share of $0.74 for the current quarter, Zacks Investment Research reports. Twenty Two analysts have issued estimates for athenahealth’s earnings. The highest EPS estimate is $0.90 and the lowest is $0.38. athenahealth posted earnings of $0.32 per share during the same quarter last year, which would suggest a positive year-over-year growth rate of 131.3%. The firm is expected to report its next quarterly earnings report on Thursday, April 26th.

On average, analysts expect that athenahealth will report full year earnings of $3.79 per share for the current fiscal year, with EPS estimates ranging from $3.10 to $4.15. For the next fiscal year, analysts anticipate that the company will post earnings of $4.49 per share, with EPS estimates ranging from $3.72 to $5.42. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side analysts that cover athenahealth.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Thursday, February 1st. The health services provider reported $1.11 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.63 by $0.48. The firm had revenue of $329.20 million for the quarter, compared to analysts’ expectations of $319.64 million. athenahealth had a net margin of 4.35% and a return on equity of 9.21%. The business’s revenue was up 14.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.62 EPS.

Several research firms have weighed in on ATHN. Royal Bank of Canada set a $141.00 price target on shares of athenahealth and gave the company a “hold” rating in a report on Thursday, February 15th. SunTrust Banks increased their price target on shares of athenahealth to $180.00 and gave the company a “buy” rating in a report on Monday, February 5th. BidaskClub cut shares of athenahealth from a “sell” rating to a “strong sell” rating in a report on Saturday, February 3rd. Canaccord Genuity increased their price target on shares of athenahealth from $123.00 to $137.00 and gave the company a “hold” rating in a report on Thursday, February 1st. Finally, Evercore ISI began coverage on shares of athenahealth in a report on Thursday, January 18th. They issued an “in-line” rating and a $140.00 price target on the stock. Three research analysts have rated the stock with a sell rating, seventeen have given a hold rating and seven have given a buy rating to the company. athenahealth presently has a consensus rating of “Hold” and a consensus target price of $144.35.

athenahealth stock opened at $139.26 on Friday. The firm has a market cap of $5,584.05, a PE ratio of 106.31, a price-to-earnings-growth ratio of 2.41 and a beta of 1.17. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.32. athenahealth has a fifty-two week low of $95.01 and a fifty-two week high of $158.66.

In related news, CEO Jonathan Bush sold 30,000 shares of athenahealth stock in a transaction that occurred on Tuesday, December 26th. The shares were sold at an average price of $134.80, for a total value of $4,044,000.00. Following the transaction, the chief executive officer now directly owns 320,807 shares of the company’s stock, valued at $43,244,783.60. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Bradford Kyle Armbrester sold 2,235 shares of athenahealth stock in a transaction that occurred on Friday, March 2nd. The shares were sold at an average price of $138.70, for a total transaction of $309,994.50. Following the completion of the transaction, the senior vice president now directly owns 10,146 shares in the company, valued at $1,407,250.20. The disclosure for this sale can be found here. Insiders sold 108,705 shares of company stock worth $14,891,199 over the last three months. 3.20% of the stock is currently owned by insiders.

Large investors have recently made changes to their positions in the stock. American International Group Inc. bought a new position in athenahealth in the fourth quarter valued at approximately $124,000. Meadow Creek Investment Management LLC bought a new position in athenahealth in the fourth quarter valued at approximately $132,000. The Manufacturers Life Insurance Company increased its stake in athenahealth by 7.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,179 shares of the health services provider’s stock valued at $166,000 after acquiring an additional 84 shares during the last quarter. Columbia Partners L L C Investment Management bought a new position in athenahealth in the fourth quarter valued at approximately $204,000. Finally, LPL Financial LLC bought a new position in athenahealth in the fourth quarter valued at approximately $207,000.

ILLEGAL ACTIVITY NOTICE: “Zacks: Brokerages Expect athenahealth, Inc (ATHN) to Post $0.74 EPS” was first posted by Ticker Report and is owned by of Ticker Report. If you are reading this piece of content on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark legislation. The original version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3298997/zacks-brokerages-expect-athenahealth-inc-athn-to-post-0-74-eps.html.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Get a free copy of the Zacks research report on athenahealth (ATHN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Deutsche Bank AG Has $2.13 Million Position in Bryn Mawr Bank Co.
Deutsche Bank AG Has $2.13 Million Position in Bryn Mawr Bank Co.
Archrock, Inc.  Shares Bought by Deutsche Bank AG
Archrock, Inc. Shares Bought by Deutsche Bank AG
Deutsche Bank AG Has $2.20 Million Stake in Ichor Holdings
Deutsche Bank AG Has $2.20 Million Stake in Ichor Holdings
Deutsche Bank AG Reduces Position in Andeavor Logistics
Deutsche Bank AG Reduces Position in Andeavor Logistics
New Home Company Inc  Stake Lifted by Deutsche Bank AG
New Home Company Inc Stake Lifted by Deutsche Bank AG
Invesco Senior Income Trust  Shares Sold by Guggenheim Capital LLC
Invesco Senior Income Trust Shares Sold by Guggenheim Capital LLC


© 2006-2018 Ticker Report. Google+.